708 event(s) found
Update PDT-PDD 2026 (Photodynamic Therapy and Photodiagnosis)
International update on photodynamic therapy and photodiagnosis, including oncological applications.
ESGCT 2026 - 33rd Annual Congress of the European Society of Gene and Cell Therapy
33rd annual congress of the European Society of Gene and Cell Therapy, in collaboration with the German Society for Gene Therapy (DG-GT), covering gene therapy, gene editing and cell therapies including CAR-T.
Brazilian Congress of Hematology, Hemotherapy and Cell Therapy
After being held in São Paulo for four years, the Brazilian Congress of Hematology, Hemotherapy and Cell Therapy - the traditional HEMO — returns to Rio de Janeiro, reaffirming the city as one of the country’s main hubs for scientific events. Organized by the Brazilian Association of Hematology, Hemotherapy and Cell Therapy (ABHH), the congress is the largest in the field in Latin America and ranks among the most relevant worldwide, bringing together thousands of specialists from Brazil and abroad. HEMO 2026 will feature 10 concurrent thematic tracks organized by specialty area: Transfusion Medicine, Cell Therapy, Hematologic Oncology, Pediatric Hematology, Hemostasis and Thrombosis, Anemias, Flow Cytometry, Laboratory Hematology, Palliative Care, Multidisciplinary Sessions.
EBMT Joint Lymphoma Working Party and Cellular Therapy and Immunobiology Working Party Educational Meeting
Joint educational meeting of two EBMT working parties on transplantation and cellular therapies (CAR-T) in lymphoma.
IOCHe2026 – 1st International Online Conference on Hematology
The 1st International Online Conference on Hematology (IOCHe2026)—organized by the MDPI journals Hemato, Hematology Reports, and Thalassemia Reports—will bring together researchers to share the latest developments in the field, from anemia and transfusion medicine to leukemia and rare blood disorders. Participants are encouraged to present their work and engage with colleagues worldwide. Registration and abstract submission are free of charge.
5th How to Diagnose and Treat Lymphoma
ESH educational conference on the diagnosis and treatment of lymphomas, for haematologists and oncologists in training and practice.
6ª Jornadas Latinoamericanas de la SAH (6th Latin American Meeting of the Argentine Society of Hematology)
Latin American meeting of the Argentine Society of Hematology covering lymphomas, MDS, AML, CML, myeloma, CLL, ALL, transplantation, haemostasis and AI in haematology.
20th CMA National Conference of Hematology (中华医学会第二十次血液学学术会议)
National congress of the Chinese Society of Hematology (Chinese Medical Association), covering malignant and non-malignant hematology, transplantation and cellular therapy. Co-hosted by the Chongqing Medical Association, Tongji Medical College Institute of Hematology and Xinqiao Hospital.
12th Academic Conference on Multidisciplinary Minimally Invasive Interventional Oncology and Targeted Therapy (第十二届肿瘤微创介入治疗多学科与靶向治疗学术会议)
National meeting on minimally invasive interventional oncology, covering hybrid interventional suites with image fusion, multidisciplinary management of liver cancer and liver metastases, and targeted and immune therapies.
39th Annual Meeting of the Japan Psycho-Oncology Society (第39回日本サイコオンコロジー学会総会)
National meeting on psychological and psychiatric care of people with cancer and their families.
14th China Cervical Cancer Prevention and Control Project Annual Conference (第十四届中国宫颈癌防治工程学术年会)
Annual national conference of the China cervical cancer prevention and control programme, focused on screening, prevention and management of cervical cancer.
IV Jornadas de pacientes con síndromes mielodisplásicos
Fourth information day for patients with myelodysplastic syndromes and their families, listed in the SEHH agenda.
2026 Tianjin Anti-Cancer Association Tumor Nuclear Medicine Committee Annual Meeting (2026天津市抗癌协会肿瘤核医学专业委员会学术年会)
Annual meeting of the Tianjin Anti-Cancer Association committee on nuclear medicine in oncology (molecular imaging and radionuclide therapy). Regional (municipal) meeting.
Upper Midwest Blood Cancer Conference 2026
One-day regional Blood Cancer United (formerly LLS) conference for patients, caregivers and healthcare professionals, with expert sessions on leukemia, lymphoma, myeloma and MDS/MPN treatment and survivorship.
Sydney GP Dermoscopy Workshop: Melanoma in Focus
Half-day introductory dermoscopy workshop for general practitioners focused on the early detection of melanoma.
13th BioCentury-BayHelix China Healthcare Summit
Annual investor and partnering summit on China's biopharma innovation, covering licensing deals, new company creation and cross-border dealmaking. In-person days in Shanghai are followed by virtual partnering days.
3e Rencontre régionale de la recherche en oncologie - Grand Est
Regional oncology research meeting of Grand Est focused on thoracic cancers: scientific advances, research dynamics, challenges and perspectives.
EACR Conference: Chromosomes in Crisis: From Chromosomal Instability to Catastrophes in Cancer Genomes
European Association for Cancer Research event: Chromosomes in Crisis: From Chromosomal Instability to Catastrophes in Cancer Genomes.
ELRIG’s French Forum:Single cell and spatial biology
Single-cell technologies integrated with spatial biology are transforming drug discovery and our understanding of human biology by revealing how cellular diversity, state, and microenvironment drive health and disease. Together, these approaches enable precise target identification and validation by linking molecular mechanisms to specific cell contexts. They expose the cellular ecosystems underlying complex diseases, uncover drivers of resistance and adverse events, and guide design of modality-appropriate interventions that act on the right cells in the right locations. Integration of single-cell and spatial readouts will yield actionable, mechanistic maps of human tissues, accelerating translation from target discovery to clinical impact. This forum will explore the recent advances that are driving this explosion in understanding whilst showcasing the impact it is having.
ELRIG’s French Forum: Single cell and spatial biology
Single-cell technologies integrated with spatial biology are transforming drug discovery and our understanding of human biology by revealing how cellular diversity, state, and microenvironment drive health and disease. Together, these approaches enable precise target identification and validation by linking molecular mechanisms to specific cell contexts. They expose the cellular ecosystems underlying complex diseases, uncover drivers of resistance and adverse events, and guide design of modality-appropriate interventions that act on the right cells in the right locations. Integration of single-cell and spatial readouts will yield actionable, mechanistic maps of human tissues, accelerating translation from target discovery to clinical impact. This forum will explore the recent advances that are driving this explosion in understanding whilst showcasing the impact it is having.
37e Congrès de la Société Française de Radiothérapie Oncologique (SFRO 2026)
37th congress of the French society of radiation oncology for oncologists, medical physicists, radiation therapists and researchers: technological innovations, clinical advances (brachytherapy, re-irradiation, breast and bladder cancers), regulatory and organisational issues, young researcher sessions.
SITC 2026 - 41st Annual Meeting & Pre-Conference Programs
41st Annual Meeting of the Society for Immunotherapy of Cancer, the leading meeting dedicated to cancer immunotherapy, with pre-conference programs, scientific sessions, late-breaking abstracts and early-career awards.
ESSO 45 - 45th Congress of the European Society of Surgical Oncology
45th ESSO congress, theme 'Surgical Oncology without Borders: Innovations and Challenges Worldwide', Europe's leading event on surgical cancer care and multidisciplinary approaches.
2026 Nanets Multidisciplinary NET Medical Symposium
Join us for a premier opportunity to expand your knowledge, connect with peers, and engage in meaningful conversations about the evolving landscape of NET diagnosis and treatment.